Michael has over 12 years of experience in technology startups, venture financing, and business development. Fueled by a profound interest in sustainable development and impact investing, his current focus centers on establishing companies with innovative scientists in the fields of food, health, and wellbeing. Over the past three years, he has dedicated his efforts to creating companies with leading scientists in these domains. Before co-founding Arkeon, Michael served as Principal at EVIG Group, playing a pivotal role in constructing a portfolio of alternative protein companies. This portfolio included cultivated meat, precision fermentation, and microbial fermentation. During this tenure, the group successfully secured EUR 40 million in combined funding for its portfolio to date. Michael's commitment to company building is rooted in his diverse background, encompassing work in creative industries, startups, and venture capital. He held positions at Monoqi, a Berlin-based venture-backed startup, and Middle East Venture Partners, one of the largest venture capital firms in the Middle East.
4.2H - Silk Road Hall
Food from CO2? Austrian biotech scaleup, Arkeon, tackles greenhouse gas emissions by converting carbon dioxide into essential protein ingredients through gas fermentation. The company produces all 20 amino acids directly from archaea microbes, carbon dioxide, and hydrogen — without agricultural inputs. This groundbreaking technology not only reduces heavy industry's environmental footprint via onsite carbon capture and utilization, but also promises a sustainable and cost-effective approach to food production.